Alternatively, the recently developed UCSF-Cancer of the Prostate Risk Assessment (CAPRA) score [4] is more informative due to ease of calculation and inclusion of key clinical variables including age, PSA, percent of cores positive in biopsy (%core), clinical T stage, and Gleason patterns. This evidence concerns the gene KLK3 and cancer.